Literature DB >> 26615810

A two-stage treatment of lentigo maligna using ablative laser therapy followed by imiquimod: excellent cosmesis, but frequent recurrences on the nose.

K Greveling1, K de Vries2, M B A van Doorn3, E P Prens3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 26615810     DOI： 10.1111/bjd.14330

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN： 0007-0963            Impact factor:   9.302


× No keyword cloud information.
  2 in total

1.  Lentigo maligna - anatomic location as a potential risk factor for recurrences after non-surgical treatment.

Authors:  K Greveling; Th van der Klok; M B A van Doorn; V Noordhoek Hegt; E P Prens
Journal:  J Eur Acad Dermatol Venereol       Date:  2016-09-19       Impact factor: 6.166

2.  Nine per cent of biopsy-proven lentigo maligna lesions are reclassified as lentigo maligna melanoma after surgery.

Authors:  J Zoutendijk; D Tio; S Koljenovic; R R van den Bos
Journal:  Br J Dermatol       Date:  2019-04-15       Impact factor: 9.302
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.